share_log

诺瓦瓦克斯与赛诺菲达成许可协议,诺瓦瓦克斯医药美股盘前股价一度涨超40%。

Novavax reached a licensing agreement with Sanofi, and the US stock price of Novavax Pharmaceuticals once rose more than 40% before the market.

Zhitong Finance ·  May 10 16:11
Novavax reached a licensing agreement with Sanofi, and the US stock price of Novavax Pharmaceuticals once rose more than 40% before the market.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment